GNH USA

USA — NDC

KEYTRUDA 25 mg/mL

KEYTRUDA 25 mg/mL is a solution for injection used in cancer treatment. This medication, containing pembrolizumab, is designed to help the immune system fight c

Pembrolizumab
KEYTRUDA
INJECTION, SOLUTION
25 mg/mL

Request sourcing

1
Pack/s

What is Pembrolizumab?

KEYTRUDA 25 mg/mL is a solution for injection used in cancer treatment. This medication, containing pembrolizumab, is designed to help the immune system fight cancer cells. Learn more about KEYTRUDA and its uses.

What is Pembrolizumab used for?

KEYTRUDA 25 mg/mL is primarily used in cancer treatment. It works by helping the immune system recognize and attack cancer cells. This medication is often used for various types of cancer, including melanoma, lung cancer, and others. What is KEYTRUDA used for? It is typically prescribed for conditions where the immune system needs support to target cancer cells effectively.

What are the side effects of Pembrolizumab?

Common effects of KEYTRUDA 25 mg/mL may include fatigue, cough, nausea, and itching. Some individuals might experience more severe side effects, such as difficulty breathing or swelling. It's important to monitor any changes in health while using this medication.

What precautions apply to Pembrolizumab?

KEYTRUDA 25 mg/mL should be handled with care. It is intended for intravenous use and should be administered by healthcare professionals. Always follow the guidelines provided by your healthcare provider to ensure safe usage. Store the medication as directed to maintain its effectiveness.

What does Pembrolizumab interact with?

KEYTRUDA 25 mg/mL may interact with other medications, including those that affect the immune system. It's important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain supplements might also interact with this medication.

Frequently asked questions

What is KEYTRUDA 25 mg/mL used for?+
KEYTRUDA 25 mg/mL is used in cancer treatment to help the immune system fight cancer cells.
How is KEYTRUDA 25 mg/mL administered?+
KEYTRUDA 25 mg/mL is administered intravenously by healthcare professionals.
What are the common side effects of KEYTRUDA 25 mg/mL?+
Common side effects may include fatigue, cough, nausea, and itching.
Can KEYTRUDA 25 mg/mL be used with other medications?+
It's important to consult your healthcare provider about potential interactions with other medications.
How should KEYTRUDA 25 mg/mL be stored?+
Follow the storage guidelines provided by your healthcare provider to maintain the medication's effectiveness.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Pembrolizumab
Brand
KEYTRUDA
Strength
25 mg/mL
Form
INJECTION, SOLUTION
Route
INTRAVENOUS
Pack size
2 VIAL in 1 CARTON (0006-3026-04) / 4 mL in 1 VIAL (0006-3026-01)
Manufacturer
Merck Sharp & Dohme LLC
Origin
USA

Related products